Dai-ichi Life Insurance Company’s Stryker SYK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.51M | Buy |
13,721
+700
| +5% | +$251K | 0.13% | 157 |
|
|
2025
Q4 | $4.58M | Sell |
13,021
-6,273
| -33% | -$2.29M | 0.12% | 167 |
|
|
2025
Q3 | $7.13M | Sell |
19,294
-3,531
| -15% | -$1.36M | 0.18% | 128 |
|
|
2025
Q2 | $9.03M | Buy |
22,825
+4,593
| +25% | +$1.72M | 0.25% | 89 |
|
|
2025
Q1 | $6.79M | Sell |
18,232
-83
| -0.5% | -$31.6K | 0.2% | 119 |
|
|
2024
Q4 | $6.59M | Buy |
18,315
+3,000
| +20% | +$1.11M | 0.18% | 122 |
|
|
2024
Q3 | $5.53M | Sell |
15,315
-5,000
| -25% | -$1.73M | 0.14% | 153 |
|
|
2024
Q2 | $6.91M | Sell |
20,315
-1,513
| -7% | -$513K | 0.17% | 132 |
|
|
2024
Q1 | $7.81M | Hold |
21,828
| – | – | 0.18% | 117 |
|
|
2023
Q4 | $6.54M | Sell |
21,828
-3,105
| -12% | -$871K | 0.14% | 147 |
|
|
2023
Q3 | $6.81M | Hold |
24,933
| – | – | 0.15% | 135 |
|
|
2023
Q2 | $7.61M | Hold |
24,933
| – | – | 0.16% | 124 |
|
|
2023
Q1 | $7.12M | Sell |
24,933
-1,956
| -7% | -$519K | 0.16% | 128 |
|
|
2022
Q4 | $6.57M | Buy |
26,889
+12,000
| +81% | +$2.72M | 0.15% | 134 |
|
|
2022
Q3 | $3.02M | Sell |
14,889
-135
| -0.9% | -$28.4K | 0.07% | 220 |
|
|
2022
Q2 | $2.99M | Buy |
15,024
+8,000
| +114% | +$1.88M | 0.07% | 234 |
|
|
2022
Q1 | $1.88M | Buy |
7,024
+4,000
| +132% | +$1.04M | 0.03% | 354 |
|
|
2021
Q4 | $809K | Sell |
3,024
-279
| -8% | -$73.2K | 0.01% | 442 |
|
|
2021
Q3 | $871K | Sell |
3,303
-313
| -9% | -$83.7K | 0.01% | 432 |
|
|
2021
Q2 | $939K | Sell |
3,616
-8,277
| -70% | -$2.12M | 0.01% | 437 |
|
|
2021
Q1 | $2.9M | Hold |
11,893
| – | – | 0.04% | 294 |
|
|
2020
Q4 | $2.91M | Sell |
11,893
-11,400
| -49% | -$2.58M | 0.04% | 273 |
|
|
2020
Q3 | $4.85M | Hold |
23,293
| – | – | 0.09% | 173 |
|
|
2020
Q2 | $4.2M | Sell |
23,293
-616
| -3% | -$114K | 0.1% | 159 |
|
|
2020
Q1 | $3.98M | Hold |
23,909
| – | – | 0.15% | 148 |
|
|
2019
Q4 | $5.02M | Sell |
23,909
-19,790
| -45% | -$4.11M | 0.11% | 186 |
|
|
2019
Q3 | $9.45M | Buy |
43,699
+11,873
| +37% | +$2.55M | 0.23% | 103 |
|
|
2019
Q2 | $6.54M | Hold |
31,826
| – | – | 0.16% | 145 |
|
|
2019
Q1 | $6.29M | Buy |
31,826
+10,000
| +46% | +$1.8M | 0.15% | 144 |
|
|
2018
Q4 | $3.42M | Hold |
21,826
| – | – | 0.09% | 223 |
|
|
2018
Q3 | $3.88M | Hold |
21,826
| – | – | 0.08% | 227 |
|
|
2018
Q2 | $3.69M | Sell |
21,826
-2,500
| -10% | -$420K | 0.09% | 230 |
|
|
2018
Q1 | $3.92M | Hold |
24,326
| – | – | 0.08% | 220 |
|
|
2017
Q4 | $3.77M | Sell |
24,326
-73,583
| -75% | -$11.2M | 0.07% | 233 |
|
|
2017
Q3 | $13.9M | Hold |
97,909
| – | – | 0.3% | 70 |
|
|
2017
Q2 | $13.6M | Buy |
97,909
+24,526
| +33% | +$3.37M | 0.3% | 64 |
|
|
2017
Q1 | $9.66M | Buy |
73,383
+10,993
| +18% | +$1.39M | 0.26% | 92 |
|
|
2016
Q4 | $7.47M | Buy |
+62,390
| New | +$7.18M | 0.22% | 118 |
|
Other funds holding SYK
VCM
GT
VPM
Dai-ichi Life Insurance Company's SYK Position: Q1 2026 in Review
Dai-ichi Life Insurance Company increased its Stryker (SYK) stake by 5.4% in Q1 2026, buying an estimated $251K and bringing the position to 13,721 shares worth $4.51M. The position accounts for 0.13% of the portfolio, ranked #157.
Dai-ichi Life Insurance Company first reported a position in SYK in Q4 2016 and has held it in 38 quarters since. The position peaked at $13.9M in Q3 2017. 2,299 funds tracked by Wall St. Rank hold SYK as of Q1 2026.
- Dai-ichi Life Insurance Company held 13,721 shares of Stryker worth $4.51M as of Q1 2026.
- Dai-ichi Life Insurance Company bought 700 Stryker shares in Q1 2026, an estimated $251K.
- Stryker made up 0.13% of Dai-ichi Life Insurance Company's portfolio in Q1 2026, its #157 holding.
- Dai-ichi Life Insurance Company first reported a position in Stryker in Q4 2016 and has held it in 38 quarters since.
- Dai-ichi Life Insurance Company's Stryker position peaked at $13.9M in Q3 2017.
- 2,299 funds tracked by Wall St. Rank held Stryker as of Q1 2026.
Based on Dai-ichi Life Insurance Company's 13F filing for Q1 2026, filed 14 May 2026.